As the number of precision medicines grows, so does the challenge of assuring their quality. Solutions are waiting in the wings.
Amid privacy concerns, the tech giant plans to monitor mobility, menstruation and hearing via users’ Apple watches and iPhones
Japan has turned regenerative medicine into a regulatory free-for-all. Patients across the world could pay the price
A common gene-editing enzyme could be used to disable RNA viruses such as flu or Ebola
As the country seeks to become a research powerhouse, it must rectify worrisome practices
Research into molecular biomarkers is quickly moving from the lab to the clinic. It promises to transform how doctors diagnose and treat disease.
Gene transcription is one of life’s most fundamental processes. For the first time, researchers have viewed it in real time in a living cell.
To avoid stagnated growth and labor shortfalls, the U.S. must rethink its approach now
What can our genes tell us about which diet will work best for us?
You can find good information, but there's a lot more bad
An elaborate setup allowed researchers to study how people stumble and recover
Rapid molecular tests for influenza are as quick as older on-the-spot tests and much more accurate. But that might not be enough to drive widespread adoption.
Scientists can track influenza in real time by monitoring social media, leading to more accurate predictions.
Companies such as 23andMe and Ancestry.com have made it impossible for sperm banks to keep donors’ identities secret
The research could eventually lead to new sources of organs for transplant, but ethical and technical hurdles need to be overcome
Discount coupons let patients pin down costs before treatment, but raise worries about unnecessary tests and radiation
The CRISPR technique can trigger the new material to release drugs or pick up biological signals
At-home video sessions and apps could reduce costs and expand treatment in rural areas
Patients can pay hundreds to thousands of dollars to screen for genetic health risks